pRB plays an essential role in cell cycle arrest induced by DNA damage

Tekijä Harrington, Elizabeth A., Bruce, Jacqueline L., Harlow, Ed, Dyson, Nicholas
Julkaistu 1998

Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA

Tekijä Rowlands, Vicky, Rutkowski, Andrzej J., Meuser, Elena, Carr, T. Hedley, Harrington, Elizabeth A., Barrett, J. Carl
Julkaisussa Sci Rep (2019)

Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality?

Tekijä Seiler, Caroline, Sharpe, Alan, Barrett, J. Carl, Harrington, Elizabeth A., Jones, Emma V., Marshall, Gayle B.
Julkaisussa BMC Clin Pathol (2016)

Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Tekijä Avivar-Valderas, Alvaro, McEwen, Robert, Taheri-Ghahfarokhi, Amir, Carnevalli, Larissa S., Hardaker, Elizabeth L., Maresca, Marcello, Hudson, Kevin, Harrington, Elizabeth A., Cruzalegui, Francisco
Julkaisussa Oncotarget (2018)

Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia

Tekijä Harrington, Elizabeth A., Sloan, Jennifer L., Manoli, Irini, Chandler, Randy J., Schneider, Mark, McGuire, Peter J., Calcedo, Roberto, Wilson, James M., Venditti, Charles P.
Julkaisussa Hum Gene Ther (2016)

Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images

Tekijä Joseph, Jesuchristopher, Roudier, Martine P., Narayanan, Priya Lakshmi, Augulis, Renaldas, Ros, Vidalba Rocher, Pritchard, Alison, Gerrard, Joe, Laurinavicius, Arvydas, Harrington, Elizabeth A., Barrett, J. Carl, Howat, William J.
Julkaisussa Sci Rep (2019)

First-in-human pharmacokinetic and pharmacodynamic study of the dual m-TORC 1/2 inhibitor, AZD2014

Tekijä Basu, Bristi, Dean, Emma, Puglisi, Martina, Greystoke, Alastair, Ong, Michael, Burke, Wendy, Cavallin, Maria, Bigley, Graham, Womack, Christopher, Harrington, Elizabeth A, Green, Stephen, Oelmann, Elisabeth, de Bono, Johann S, Ranson, Malcolm, Banerji, Udai
Julkaisussa Clin Cancer Res (2015)

ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation

Tekijä Barlow, Carrolee, Ribaut-Barassin, Catherine, Zwingman, Theresa A., Pope, Amber J., Brown, Kevin D., Owens, Jennie W., Larson, Denise, Harrington, Elizabeth A., Haeberle, Anne-Marie, Mariani, Jean, Eckhaus, Michael, Herrup, Karl, Bailly, Yannick, Wynshaw-Boris, Anthony
Julkaistu 2000

Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon

Tekijä Rooney, Claire, Geh, Catherine, Williams, Victoria, Heuckmann, Johannes M., Menon, Roopika, Schneider, Petra, Al-Kadhimi, Katherine, Dymond, Michael, Smith, Neil R., Baker, Dawn, French, Tim, Smith, Paul D., Harrington, Elizabeth A., Barrett, J. Carl, Kilgour, Elaine
Julkaisussa PLoS One (2016)

pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry

Tekijä Jones, Gemma N., Rooney, Claire, Griffin, Nicola, Roudier, Martine, Young, Lucy A., Garcia-Trinidad, Antonio, Hughes, Gareth D., Whiteaker, Jeffrey R., Wilson, Zena, Odedra, Rajesh, Zhao, Lei, Ivey, Richard G., Howat, William J., Harrington, Elizabeth A., Barrett, J. Carl, Ramos-Montoya, Antonio, Lau, Alan, Paulovich, Amanda G., Cadogan, Elaine B., Pierce, Andrew J.
Julkaisussa Br J Cancer (2018)